Analytica Share Price and Company Fundamentals



Price
$0.002
Change
0.000 (0.000%)
52 week
0.001 - 0.006

Last traded: Last Thursday at 12:00 AM

Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

Beta

0.54

Market cap

$9.23M

Enterprise value

$7.34M

Company profile

Primary activitiesAnalytica is a medical device commercialisation company with focus on late-stage, low regulatory risk products. Products include the PeriCoach (R) system for treatment of female urinary incontinence and other pelvic floor health conditions, .
Industry / SectorMedical Devices / Healthcare
Websitehttp://www.analyticamedical.com
Mailing address320 Adelaide Street Brisbane QLD 4000 Australia
Phone / Fax61 7 3278 1950 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Analytica does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Analytica.

NameTitleAgeTotal Pay
Dr. Michael MonsourExec. Chairman
Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPEChief Exec. Officer
Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICDCFO & Exec. Director
Ms. Chelsea CorneliusChief Operating Officer
Ms. Megan HenkenVP of Global Marketing
Mr. Bryan Dulhunty ACA, BEc, C.A.Company Sec.19.07k

Profitability and management effectiveness

Profit margin

-188.09%

Operating margin

-180.45%

Return on assets

-55.18%

Return on equity

-144.55%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Analytica is 9.23M and its enterprise value is 7.34M. The enterprise value to revenue ratio of ALT is 9.15.

The ALT's stocks Beta value is 0.54 making it 46% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Analytica (ALT)

Analytica (ASX:ALT) Frequently Asked Questions

1. What is Analytica's Stock Symbol?

Analytica trades on ASX under the ticker symbol "ALT".

2. What is Analytica's stock price today?

One share of ALT stock can currently be purchased for approximately $0.002.

3. How can I contact Analytica?

Analytica's mailing address is 320 Adelaide Street Brisbane QLD 4000 Australia. The company can be reached via phone at 61 7 3278 1950.

4. What is Analytica's official website?

The official website of Analytica is http://www.analyticamedical.com.

5. Which share registry manages Analytica's stock?

Analytica's stock is managed by LINK MARKET SERVICES LIMITED.